The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of asciminib (ASC) in patients (pts) with chronic-phase chronic myeloid leukemia (CML-CP) after 1 tyrosine kinase inhibitor (TKI): Interim analysis (IA) of the phase 2 ASC2ESCALATE trial.
 
David Andorsky
Consulting or Advisory Role - Abbvie; Celgene
Research Funding - Abbvie; AstraZeneca; Celgene; Novartis
 
Marlise Luskin
Consulting or Advisory Role - Jazz Pharmaceuticals; Kite, a Gilead company; Novartis; Pfizer
Research Funding - Abbvie (Inst); Novartis (Inst)
 
Srinivas Tantravahi
Honoraria - CTI BioPharma Corp; Genentech; GlaxoSmithKline; Karyopharm Therapeutics; Novartis
Consulting or Advisory Role - CTI BioPharma Corp; Genentech; GlaxoSmithKline; Karyopharm Therapeutics; Novartis
Research Funding - Karyopharm Therapeutics
 
Koji Sasaki
Honoraria - Amgen; Chugai Pharma; Otsuka
Consulting or Advisory Role - Novartis; Pfizer; Takeda
Research Funding - Novartis
Travel, Accommodations, Expenses - Amgen; Otsuka
 
James Dugan
Consulting or Advisory Role - Abbvie; Astellas Pharma; ReachMD
Speakers' Bureau - Abbvie; Astellas Pharma; Bristol Myers Squibb Foundation; Rigel
 
Celeste Bremer
No Relationships to Disclose
 
Vivian Oehler
Consulting or Advisory Role - Novartis; Takeda; Terns Pharmaceuticals
 
Joshua Zeidner
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb/Celgene; Daiichi Sankyo/UCB Japan; Foghorn Therapeutics; Genentech; Genmab; Gilead Sciences; Immunogen; NeoGenomics Laboratories; Novartis; Sellas Life Sciences; SERVIER; Shattuck Labs; Sumitomo Pharma Oncology; Syndax; Takeda
Research Funding - Abbvie (Inst); Akeso Biopharma (Inst); Arog (Inst); Astex Pharmaceuticals (Inst); AstraZeneca (Inst); Faron Pharmaceuticals (Inst); Gilead Sciences (Inst); Jazz Pharmaceuticals (Inst); Loxo (Inst); Merck (Inst); Newave Pharmaceutical (Inst); Novartis (Inst); Sellas Life Sciences (Inst); Shattuck Labs (Inst); Stemline Therapeutics (Inst); Sumitomo Dainippon Pharma Oncology (Inst); Zentalis (Inst)
 
Moshe Levy
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; BeiGene; Bristol Myers Squibb Foundation; Epizyme; Gilead Sciences; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Kite, a Gilead Company; MorphoSys; Novartis; Seagen; Takeda; TG Therapeutics
Speakers' Bureau - Abbvie; Amgen; AstraZeneca; BeiGene; Bristol-Myers Squibb Foundation/Janssen; Epizyme; Gilead Sciences; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Kite, a Gilead Company; MorphoSys; Novartis; Seagen; Takeda; TG Therapeutics
 
Camille Abboud
Stock and Other Ownership Interests - Abbott Laboratories (I); Abbvie (I); Johnson & Johnson (I)
Consulting or Advisory Role - Cardinal Health
Research Funding - Gilead Sciences (Inst); Novartis (Inst); TargetRx (Inst)
 
Ehab Atallah
Honoraria - Novartis
 
Paul Koller
Honoraria - Novartis; Takeda
Consulting or Advisory Role - Ascentage Pharma; Daiichi Sankyo/Lilly; Novartis; Takeda; Treadwell Therapeutics
Speakers' Bureau - Novartis; Takeda
 
Bonnie Kiner-Strachan
Employment - Johnson & Johnson (I)
Stock and Other Ownership Interests - Esperion Therapeutics; Gossamer Bio; Johnson & Johnson; Pfizer; Viatris
 
Habte Yimer
No Relationships to Disclose
 
Daisy Yang
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
J. Sabo
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Bridget Cooper
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Dheeraj Gianchandani
Employment - Novartis
 
Jorge Cortes
Consulting or Advisory Role - Bio-Path Holdings, Inc; Enliven Therapeutics; Gilead Sciences; Novartis; Pfizer; Rigel; Sun Pharma; Syndax; Takeda; Terns Pharmaceuticals
Research Funding - Abbvie/Genentech (Inst); Actuate Therapeutics (Inst); Bio-Path Holdings, Inc (Inst); Cyto Agents (Inst); Jazz Pharmaceuticals (Inst); Kuro Oncology (Inst); Novartis (Inst); Pfizer (Inst); Sellas Life Sciences (Inst); Sun Pharma (Inst)
 
Michael Mauro
Honoraria - Bristol Myers Squibb Foundation; Novartis; Pfizer; Takeda
Consulting or Advisory Role - Bristol Myers Squibb Foundation; Novartis; Pfizer; Takeda
Research Funding - Bristol Myers Squibb Foundation; Novartis; Sun Pharma; Takeda